Skip to main content
. 2015 Sep 3;1(2):2055116915600454. doi: 10.1177/2055116915600454

Table 1.

Sequential clinical findings. Western immunoblot (WB), PCR, Bartonella alpha Proteobacteria growth medium (BAPGM) blood culture/PCR/DNA sequencing results and post-treatment Western blot antibody titration titers for three febrile Bartonella henselae-infected kittens

Date Clinical findings Bartonella WB and titration titers Blood PCR BAPGM culture
PCR
Case 1 3 September 2012 Temperature 39.8°C, lethargy Negative Negative Negative
5 September 2012 Negative Negative
7 September 2012 Negative Negative
11 October 2012 Temperature 40.8°C, lethargy Negative Bh * Bh *
Azithromycin 10 mg/kg for 21 days Bh *
12 November 2012 1:256,000
12 May 2013 Titration testing 1:16,000 (16-fold decrease)
28 August 2014 Follow-up
testing
ND Negative Bh
30 August 2014 ND Negative Negative
1 September 2014 1:16,000
(no change)
Negative Negative
Case 2 21 August 2012 Presurgery 1:512,000
3 September 2012 40.0°C, lethargy ND Bh* Bh*
5 September 2012 ND Bh* Bh*
7 September 2012 Azithromycin
10 mg/kg for 21 days
ND Bh* Bh*
2 March 2013 39.8°C, lethargy anorexia 1:512,000 Bh* Bh*
Pradofloxacin 7.5 mg/kg x 21 days (no change) Bh*
5 September 2013 Titration testing 1:64,000
(eight-fold decrease)
30 May 2014 Killed by dogs and lost to follow-up
Case 3 23 August 2012 37.7°C, lethargy anorexia neutropenia Azithromycin 10 mg/kg for 21 days 1:64,000 Bh* Bh*
7 May 2013 Titration testing 1:8,000
(eight-fold decrease)
28 August 2014 Follow-up
BAPGM triple blood draw and titration testing
ND Bh* Bh*
30 August 2014 ND Bh* Bh*
1 September 2014 1:32,000
(four-fold decrease)
Negative Bh*
*

Bartonella henselae Houston-1 strain type based upon 16S-23S intergenic spacer DNA sequences

Bartonella henselae San Antonio-2 strain type based upon 16S-23S intergenic spacer DNA sequences

ND = not determined